Patents Assigned to Sosei R&D Ltd
  • USE OF GLYCOPYRROLATE FOR TREATING TACHYCARDIA
    Publication number: 20140080890
    Abstract: The invention relates to a novel use of the antimuscarinic agent glycopyrrolate, for example the salt glycopyrronium bromide. In particular, the invention relates to glycopyrrolate for use as a heart rate lowering agent and more particularly, but not exclusively, for use in patients suffering from respiratory conditions such as chronic obstructive pulmonary disease.
    Type: Application
    Filed: March 5, 2012
    Publication date: March 20, 2014
    Applicant: SOSEI R&D LTD
    Inventors: Susan Snape, Robert Tansley
  • Treatment of respiratory disease
    Patent number: 7229607
    Abstract: A pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours.
    Type: Grant
    Filed: October 7, 2002
    Date of Patent: June 12, 2007
    Assignee: Sosei R&D Ltd
    Inventors: Robin Mark Bannister, Andrew John McGlashan Richards, Julian Clive Gilbert, David A. V. Morton, John Staniforth